The future of oncology is here. For many years doctors have tried their best treating cancer almost blindly. They are yet to establish the exact cause of cancer and the treatment they use are not 100% successful. However, there has been a recent development in this field of cancer treatment that promises to shed light in the darkness and make the doctors work easier; the discovery of whole genome sequencing (WGS).
Whole genome sequencing is a test that is able to reveal genetic errors in the patients’ genetic composition. This allows the doctors to compare the cancerous cells to normal ones. Doctors have explained that the reason they are yet to find a cure for cancer is that they have no way of knowing what exactly triggered the growth of the cancerous cells. But now, with the discovery of this new test, they are able to determine exactly what is wrong at the cell level.
Because of the results it promises, many experts like Clay Siegall are excited about it and are conducting extensive research on it. Dr. Clay says with the promise it holds, WGS will enable the doctors to treat cancer more effectively since they will be able to customize treatment to each patient depending on the cause of the cancer that ails them. He also thinks that it will also make it easy to prevent cancer in those who are not sick. By knowing which genes are erratic, they will be able to separate and remove genes that may cause cancer later in life.
The diagnosis of cancer also has changed for the better. The redbout MC teaching hospital have already experienced success in diagnosing prostate cancer at a very early stage thus making treatment easier.
Dr. Clay Siegall – CEO, Seattle Genetics, fully supports this new finding. He says that with the new discoveries being made in the field of oncology, there is no need to keep holding on to the old methods that end up costing more lives than saving them. He and his company are throwing their energy and resources in conducting more research in new ways of treating and diagnosing cancer.